Structural Formula Dextrose (Lmd 01)
Lmd In Sodium Chloride Injection, Solution
Product Images NDC 0409-7419
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lmd In Sodium Chloride (NDC 0409-7419). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Hospira Logo (Lmd 02)
Bag Ndc 0409-7418-13 (Lmd 03)
This is a description of a medication called Dextran 40 in Dextrose Injection, USP. It is a sterile, nonpyrogenic solution that comes in a 500 mL container. Each 100 mL of the solution contains 10g Dextran 40 and 59 Dextrose. It is for intravenous use only and should not be used in series connections. The usual dosage is not available, but it can be found in the insert. It is recommended to store the medication at 20 to 25°C and protect it from freezing. It is distributed by Hospira, Inc.*
Principal Display Panel (500 mL Bag Pouch Case Overwrap)
The description for this text is:
The text appears to be instructions for opening a container or package and checking for leaks. It also includes information about excessive heat and freezing precautions, as well as a statement about the product not being made with natural rubber latex. The repeated text at the end does not provide any additional information.*
Bag Ndc 0409-7419-14 (Lmd 05)
This is an injectable solution containing 10g Dextran 40 and 0.59% Sodium Chloride. It may also contain Sodium Hydroxide and/or Hydrochloric acid. Each 100 mL of the solution has 154mEq sodium and 154mEq chloride. It is sterilized, non-pyrogenic, and cannot be used as a plasma volume expander. It should not be frozen and must be stored at 20-25°C. The package doesn't contain a bacteriostatic agent and unused portions should be discarded. The solution is intended for intravenous use, and its dosage information is in the insert. The packaging is distributed by Hospira, Inc. There is also a warning that it contains DEHP.*
Principal Display Panel (500 mL Bag Pouch Case Overwrap)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
